Seeking Alpha

Lucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-Care

PCR Lab-quality NAAT/molecular test for both COVID-19 and flu from 1 shallow nasal swab Positive result as quickly as 11 minutes, negative result in 30 minutes, allowing diagnosis during patient visit ...
Business Wire

Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test

SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug ...
Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
CSR Wire

Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide

PHILADELPHIA & SECAUCUS, N.J., August 17, 2022 /CSRwire/ - Rite Aid (NYSE: RAD) announced it is collaborating with Quest Diagnostics (NYSE: DGX) to provide access to quality, COVID-19 molecular ...
Nasdaq

First-of-its-kind Cue Health Partnership with Air Canada Provides U.S.-based Customers with Special Access to the Most Accurate COVID-19 Self-Test

Air Canada Passengers can now access Cue's 24/7 supervised test for verified travel results through the Cue Health App U.S.-based Air Canada customers can now access Cue's testing services, with ...
Labroots

Overcoming the Challenges of Accuracy and Detection in Molecular Assays

Molecular diagnostic tests are currently used for infectious disease testing due to the superior sensitivity and specificity that can be obtained. Due to the success that has been obtained with this ...